Home > Boards > US OTC > Medical - Drugs > Elite Pharmaceuticals (ELTP)

As if the name of the valuation company

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Couch  Member Profile
 
Followed By 274
Posts 33,135
Boards Moderated 0
Alias Born 07/06/12
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 12/9/2021 10:47:46 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/2/2021 6:16:23 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/2/2021 6:14:39 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/15/2021 5:31:18 PM
Elite Pharmaceuticals reports FQ2 results Seeking Alpha - 11/15/2021 4:51:51 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/15/2021 4:12:10 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/16/2021 5:29:36 PM
Elite Pharmaceuticals reports Q1 results Seeking Alpha - 8/16/2021 5:05:15 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/16/2021 4:22:36 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/7/2021 5:01:22 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/1/2021 6:37:46 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/1/2021 6:31:14 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/1/2021 6:21:38 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/14/2021 5:16:46 PM
Elite Pharmaceuticals reports FY results Seeking Alpha - 6/14/2021 5:16:14 PM
Annual Report (10-k) Edgar (US Regulatory) - 6/14/2021 5:01:25 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 5/19/2021 1:29:31 PM
Elite Pharmaceuticals enters exclusive distribution agreement with Prasco Seeking Alpha - 5/4/2021 10:32:08 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/29/2021 4:02:41 PM
Elite Pharmaceuticals names Marc Bregman as chief financial officer Seeking Alpha - 4/29/2021 8:56:13 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/12/2021 6:16:33 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/16/2021 5:04:10 PM
Elite Pharmaceuticals reports FQ3 results Seeking Alpha - 2/16/2021 4:41:50 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 2/16/2021 4:23:16 PM
Couch   Saturday, 05/24/14 01:29:00 PM
Re: richme post# 110204
Post # of 364793 
As if the name of the valuation company matters one bit one way or another. It's clear that the upper limit of $2.75 will become the lower limit in about two years. And a reasonable response that Nasrat doesn't want a bunch of so called investors calling the valuation company wasting their time with a bunch of stupid questions.

It was reiterated in front of the SEC representative that the valuation was done for purposes related to the poison pill being put in place. The representative understood this was common business practice and didn't bat an eye.

Fear Uncertainty and Doubt FUD It Ain't Going To Work Here Anymore. Notice the lack of question mark.
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences